AUTL Earnings

AUTL reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 21.00M against an estimate of 21.00M, resulting in a -0.54% surprise. The EPS was -0.3, surpassing the expected -0.23 by -30.43% . The stock experienced a -9.33% price change on the earnings day and a -10.67% change over the next five days, reflecting market reactions to the results.

Following AUTL's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -9.33% on the day of the release. Over the subsequent five days, it saw a -10.67% change. Historically, AUTL's stock price tends to shift by an average of +3.30% in the 10 days leading up to earnings and +7.17% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate AUTL’s annual revenue to reach 24.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Revise Downward by -5.61% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between AUTL's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Revise Downward by -5.61% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, AUTL's stock price typically moves by +3.30% in the 10 days before its earnings and +7.17% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 24.00M.

The earnings call summary reveals mixed signals: while there are positive aspects like U.S. sales growth and new clinical trials, challenges in EU market access and CMS reimbursement changes pose risks. The Q&A section highlights uncertainties around revenue seasonality and lack of clear guidance for Q4. The company's strategic focus on expanding treatment centers and resolving reimbursement issues indicates potential for future growth, but immediate impact remains uncertain. Overall, the sentiment is neutral due to balanced positive and negative factors.